Physician profile
Danielle Johnston
NPI 1679325823
$1,826.15
in general payments reported to CMS, 2019-2025
16 companies · $1,723 in 2025
The $1,723 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $104 · 2025: $1,723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,826.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $386.25 | 2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $209.70 | 2025 | |
| Janssen Biotech, INC. | $183.87 | 2025 | Tremfya |
| Blueprint Medicines Corporation | $128.77 | 2025 | Ayvakit |
| Abbvie INC. | $124.46 | 2025 | |
| Organon LLC | $107.00 | 2025 | Vtama |
| Dermavant Sciences, INC. | $103.64 | 2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $102.57 | 2025 | Dupixent, Libtayo |
| Janssen Scientific Affairs, LLC | $97.55 | 2025 | Tremfya |
| Genzyme Corporation | $97.36 | 2025 | |
| Pfizer INC. | $93.79 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $75.37 | 2025 | Sotyktu |
| Incyte Corporation | $43.14 | 2025 | Opzelura |
| Organogenesis INC. | $32.14 | 2025 | Puraply Wound Matrix |
| Arcutis Biotherapeutics, INC. | $21.14 | 2025 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.40 | 2025 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.